Protocol Ledger

NCT07489651 · Phase II · RECRUITING

RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

Interventional Phase II clinical trial protocol NCT07489651 sponsored by Reunion Neuroscience in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-04-20 Enrollment: 160 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07489651
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)160 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07489651
Protocol FieldVerified Registry Value
NCT IdentifierNCT07489651
Consolidated Lead SponsorReunion Neuroscience
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment160 participants (ESTIMATED)
Registered Start Date2026-04-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07489651
Hospital Research SiteLocationSite Profile
University of South FloridaTampa, FLOpen Hospital Dossier ->
Atlanta Center for Medical ResearchAtlanta, GAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI